Press Release

  • US Nuclear Strikes Back Against Degradation of America’s Fisheries Seacoasts and Harbors

    US Nuclear Strikes Back Against Degradation of America’s Fisheries Seacoasts and Harbors

    Los Angeles, CA. August 27, 2019 – US Nuclear’s (OTC: UCLE) unique line of products already includes drones, air and stack monitors, water quality monitors, and even food monitors for measuring on-site industrial pollution, including harmful chemicals, bio-hazards, and radioactive toxins. Due to increasing demand, US Nuclear is now adding an industrial underwater robotic product line that features chemical, biological, and radiological sensors for constant, real-time water monitoring. These underwater robots would be deployed where they are needed most including seaports, reservoirs, water treatment plants, hatcheries, and wildlife preserves, and environmentally sensitive areas. Robert Goldstein, CEO of US Nuclear, commented “Every day we read about the degradation and loss of marine plants and animals in addition to the human sickness caused by contaminants and pollution. With these additions, we now offer a product that can efficiently monitor these pollutants continuously and in real-time so we can act quickly to mitigate the pollution.”

    Building on the success of the DroneRAD platform (UAVs mounted with CBRN sensors), US Nuclear recently teamed up with QYSEA Technology to design and build new industrial underwater robots integrated with radiological, chemical, biological, and video sensors. Backed by new knowledge and experience in the unmanned vehicle market, US Nuclear is continuing to design and build new sensor packages for the QYSEA platform to meet new mission objectives and requirements from customers. Unmanned underwater vehicles have many advantages over traditional methods used for measuring hazardous pollution, including continuous and real-time measurement with little to no downtime, more efficient, safer, cheaper, and less time-consuming. US Nuclear’s strategy is to deploy these real-time underwater robotic systems to safeguard vital locations which require constant monitoring of harmful pollutants, such as seaports, water treatment plants, and environmentally sensitive areas such as coral reefs.

    (more…)

  • US Nuclear Uplifted to OTC-QB Market

    US Nuclear Uplifted to OTC-QB Market

    Los Angeles, CA. July 29, 2019 – The continued growth of US Nuclear Corp (OTC: UCLE) has led the company to upgrade to the OTC-QB market.  US Nuclear Corp was previously listed on the OTC-Pink Marketplace, and this upgrade will help the company build shareholder value, increase visibility, and engage new investors.

    The key benefits of upgrading to OTC-QB include:

    Better Information: OTC-QB is recognized by the SEC as an established public market.  The platform enables US Nuclear to provide current public information that investors need to analyze, value, and trade UCLE.

    Efficient Market Standards: Multiple reporting standards give US Nuclear the flexibility to control reporting costs and complexity, while still providing a premium market.

    (more…)

  • US Nuclear’s All-Purpose CBRN DroneRAD Up 777% in 2019

    USN Hires New COO Rick Landry

    US Nuclear’s All-Purpose CBRN DroneRAD Up 777% in 2019

    Los Angeles, CA. June 18, 2019 – In just the first two quarters of 2019, US Nuclear’s (OTC: UCLE) DroneRAD sales are up 777% overall DroneRAD sales for 2018, and based on promised new orders, may soar even higher. Due to new advances, USN drones are now outfitted with a complete CBRN package, chemical, biological, radiation, and nuclear sensing technology.

    In addition to detecting radiation, such as radioactive gamma hot-spots or airborne particulates, the DroneRAD is also outfitted with chemical detectors and bacterial/viral collection filters. A proprietary quick-release connector on the DroneRAD allows the operator to quickly change between sensor packages to eliminate downtime, and a special air sampling system allows the chemicals, particulates, and microbes to be collected in-flight without being disrupted by the flight turbulence.

    End-users for the DroneRAD include first responders, border security, military, homeland defense, NATO military, waste disposal, oil and gas, chemical plants, nuclear power plants, and many more.

    Chemical Detection: The DroneRAD supports multiple chemical sensors at once, and includes the following list: VOC, Carbon Dioxide, Ammonia, Carbon Monoxide, Chlorine, Formaldehyde, Hydrogen, Hydrogen Sulfide, Hydrogen Cyanide, Nitric Oxide, Nitrogen Dioxide, Oxygen, Sulfur Dioxide, Methane, and more.

    Biological/Viral Collection: Utilizing special viral and bacterial filters, the DroneRAD collects these microbes and other matter at up to 99.99% efficiency. Postflight, the biological filters are sent to a laboratory for in-depth analysis. Microbes of interest may be anthrax, botulism, plague, staph, e-Coli, cholera, salmonella, listeria, typhus, and others.

    GPS and Mapping: All measurable data, such as chemical or radioactive concentration, is GPS tagged and logged/wirelessly sent back to the operator for real-time display. The data is overlaid on Google Earth Maps in real-time, so the operator can immediately see a color-coded visual map of where and when the drone flew, and what the concentration is at each point.

    Safe Harbor Act

    This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

    Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at http://www.usnuclearcorp.com

    CONTACT:

    US Nuclear Corp. (UCLE)
    Robert I. Goldstein, President, CEO, and Chairman
    Rachel Boulds, Chief Financial Officer
    (818) 883 7043
    Email: info@usnuclearcorp.com

  • US Nuclear Signs Agreement to Acquire an Interest in a Leading Fusion Power Developer

    US Nuclear Signs Agreement to Acquire an Interest in a Leading Fusion Power Developer

    US Nuclear Signs Agreement to Acquire an Interest in a Leading Fusion Power Developer & Rights to Manufacture & Sell Fusion Power Generators for Electric Power Grid

    Los Angeles, CA.  April 23, 2019 – US Nuclear Corp. (OTC-UCLE) and Magneto-Inertial Fusion Technologies, Inc. (MIFTI) have now signed an agreement which grants US Nuclear 500,000 shares of Magneto-Inertial Fusion Technologies, Inc. (MIFTI) stock, the option to acquire up to 10% (ten percent) of MIFTI, and non-exclusive worldwide rights to manufacture and sell MIFTI’s patented thermonuclear fusion power generator. MIFTI’s fusion power generator can produce clean, baseload electric power for the US and other power grids and wherever small modular electric power sources are needed. The worldwide energy market is estimated to reach $6 trillion by 2030.

    Last year, US Nuclear signed a similar agreement with MIFTEC Labs for a revolutionary new way to produce medical radioisotopes from nuclear fusion power that has several cost and safety advantages over the current nuclear fission-based methods.

    (more…)

  • The Desperate Need For Medical Isotopes

    The Desperate Need For Medical Isotopes

    The Desperate Need For Medical Isotopes

    Los Angeles, CA. March 18, 2019 – With preparations underway for manufacturing the MIFTEC Z-pinch (ZEBRA) Fusion Medical Isotope Generators, US Nuclear Corp. (OTCBB: UCLE) is one step closer to ending the dire worldwide shortage of medical isotopes.  The federal government is so desperate to find a domestic, stable supply of medical isotopes that they recently awarded over $60 million in funding to 8 projects/companies working on solutions for this demand.  Of these 8 companies, only 3 have timelines to supply medical isotopes in the near future, and of those 3, Magneto-Inertial Fusion Technologies, Inc (MIFTI, parent company to MIFTEC) has the most promising solution.  MIFTEC’s patented fusion-powered medical isotope generator can not only solve the medical isotope shortage, but the revolutionary process also offers numerous advantages to current production methods, including:

    • MIFTEC’s process is fueled by a simple isotope of hydrogen from a renewable source: seawater.
      Current production methods of medical isotopes are fission-based nuclear reactors or accelerators that require either highly enriched or low enriched uranium (HEU/LEU) to operate. These methods are costly, multi-step processes that result in nuclear waste byproducts that must be safely contained and stored for hundreds of years while being protected from theft by terrorists.
    • Due to the eco-friendly, fusion-based technology, the capital and operational costs are a fraction of that for fission or accelerator technology.  Additionally, medical isotope production costs are up to 50% less than all other current manufacturing processes.
    • The device is designed to fit into most hospitals, nuclear medicine clinics, and laboratories.  It is ideal for local, domestic production, and results in a major reduction in transportation and import costs.  Local production also solves the timeline issues of Mo-99’s 66-hour half-life.
    • No production limit problem.  Current methods to build a nuclear reactor or accelerator are time-consuming and expensive, and once finally built, these facilities have a maximum production limit.  There is currently around a $5 billion shortfall in medical isotope production. US Nuclear can build MIFTEC’s medical isotope generators in a fraction of the time and cost, with the production line continuing until demand has been filled.

    Safe Harbor Act

    This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

    Investors may find additional information regarding US Nuclear Corp. at the SEC website at http://www.sec.gov, or the company’s website at http://www.usnuclearcorp.com

    CONTACT:

    US Nuclear Corp. (UCLE)
    Robert I. Goldstein, President, CEO, and Chairman
    Rachel Boulds, Chief Financial Officer
    (818) 883 7043
    Email: info@usnuclearcorp.com

    Yahoo Finance

  • US Nuclear/FlyCam Sells Fleet of DroneRads to Saudi Arabia Civil Defense

    US Nuclear/Flycam Sells Fleet of Drone-Rads to Saudi Arabia Civil Defense

    US Nuclear/FlyCam Sells Fleet of DroneRads to Saudi Arabia Civil Defense

    Los Angeles, CA. January 23, 2019 – US Nuclear Corp. (OTCBB: UCLE) is proud to announce that it has sold a fleet of DroneRAD systems to the Saudi Arabia Civil Defense.  This order brings US Nuclear’s current order backlog to the $2,000,000 range. The DroneRAD is aerial radiation and chemical detection system which utilizes the revolutionary Neo and Zoe drones offered by FlyCAM UAV. These aerial platforms are rugged, robust, weatherproof, and can withstand high winds up to 35 knots (40 mph) and temperature extremes (-10°C / 13°F) without compromising flight capabilities. The DroneRADwill be used by the Saudi Arabia Civil Defense for national security purposes.

    The DroneRAD sensor system is designed for both radiation and chemical detection and is highly sensitive and durable even in hostile environmental conditions. Several different sensor packages are available that range from conducting neutron or gamma surveys, to measuring airborne particulates and chemical contaminants.

    (more…)

  • US Nuclear Reports 3rd Quarter 2018 Results – 35.6% Increase in Revenue

    US Nuclear Reports 3rd Quarter 2018 Results – 35.6% Increase in Revenue

    Los Angeles, CA. November 20, 2018 – US Nuclear Corp. (OTCBB: UCLE)

    • Sales for the three months ended September 30, 2018, were $1,145,480, an increase of 35.6% for the same period in 2017
    • Gross profit was $512,096, an increase of 34% for the same period in 2017
    • During the three months ended September 30, 2018, the company entered into an agreement with MIFTEC and paid $1,084,000 for certain manufacturing and supply rights as discussed below
    • Net loss from operations ($1,414,715) due to stock-based compensation and acquisition of manufacturing and supply rights offset by an increase in gross profits due to higher sales (more…)
  • US Nuclear Announces Revenue Is Up 80% Over Past 2 Years

    US Nuclear Announces Revenue Is Up 80% Over Past 2 Years

    Los Angeles, CA. October 29, 2018 – US Nuclear Corp. (OTCBB: UCLE) recently reported strong worldwide revenue growth of 80% from 2016 based on the 2018 YTD sales rate. One main factor driving the growth in revenue is a targeted sales effort of US Nuclear’s unique signature products. These products include drinking water monitors, nuclear power plant air and stack monitors, USN/FlyCAM UAV DroneRADs, personnel and vehicle monitors, and tritium monitors.

    US Nuclear Corp’s annual sales revenue for 2016 was $2,097,157 which rose to $3,070,646 for 2017.  The current 2018 YTD revenue for the first 3 quarters is $2,706,785, signifying a 2018 YTD sales rate of $3,600,000/year, an increase of 80% from 2016. Additionally, US Nuclear currently has a comfortable order backlog of $1,393,167.

    Robert Goldstein, CEO of US Nuclear Corp, commented, “Looking forward, we are very optimistic.  We have focused our sales efforts on our signature product lines, which have been gaining momentum among our sales representatives and customers as they migrate to US Nuclear’s brand due to our superior reliability, performance, and innovative functionality and capabilities not found anywhere else.”

    (more…)

  • US Nuclear Corp with Drone Partner Flycam UAV Performs Dronerad Flight Demonstration for Urban Shield Event

    US Nuclear Corp with Drone Partner Flycam UAV Performs Dronerad Flight Demonstration for Urban Shield Event

    Los Angeles, CA. September 13, 2018 – US Nuclear Corp (OTCBB: UCLE) recently attended and participated in the Urban Shield event from September 7-10, 2018 in the Bay Area.  Urban Shield is a disaster training exercise involving local, national, and international first responder agencies, including the national guard, police and fire departments, search & rescue, homeland security, FBI, FEMA, DOE, and many more.  The main goal of Urban Shield is to evaluate the preparedness and the capabilities of first responders in response to high-level threats in high-density areas and finding ways in which to improve.

    US Nuclear Corp participated in an emergency service scenario wherein a car containing radioactive material had been blown up.  Radioactive sources were placed in/near the blown-up vehicle to create a live scenario. US Nuclear Corp and their drone partner FlyCam UAV flew FlyCam UAV’s NEO octocopter equipped with US Nuclear Corp’s radiation sensor search tool, the DroneRAD-ST, over the incident area to map the radioactive hotspots before emergency responders moved in to mitigate the situation.

    US Nuclear Corp. Partner Achieves Historic Milestone for Nuclear Fusion

    FlyCam UAV’s NEO, a heavy-lifting, all-weather octocopter mounted with US Nuclear Corp’s Gamma Search Tool sensor is designed to detect radioactive Gamma emitting hotspots on the ground and log and transmit the GPS tagged data back in real-time.  The mission was successfully completed and the DroneRAD-ST mounted on FlyCam UAV’s NEO demonstrated its ability to measure and pinpoint the Gamma sources and overlay all the data on Google Maps. This provided first responders a real-time visual of the radioactive zones and where the concentration was the highest.  It was widely agreed by all the emergency service personnel present that the NEO mounted DroneRAD-ST is an essential tool that every first-responder service should have for emergencies involving radiation exposure.

    US Nuclear Corp’s unique DroneRAD-ST was the only radiation and chemical detecting UAV mounted radiation sensor present at Urban Shield. As emergency services continue to improve, there will be a greater emphasis on acquiring the special tools needed to effectively address certain emergencies, especially in high-density areas.  This includes the DroneRAD-ST detector system mounted on FlyCam UAV’s drone platforms for quick surveying and mapping radiation-related emergencies thus mitigating first responder and public exposure to potentially harmful radiation.

    Safe Harbor Act

    This press release includes “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Actual results may differ from expectations, estimates, and projections and, consequently, you should not rely on these forward-looking statements as predictions of future events. Words such as “expect,” “estimate,” “project,” “budget,” “forecast,” “anticipate,” “intend,” “plan,” “may,” “will,” “could,” “should,” “believes,” “predicts,” “potential,” “continue,” and similar expressions are intended to identify such forward-looking statements. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results.

    Investors may find additional information by visiting US Nuclear Corp. and the SEC website.

    CONTACT:

    US Nuclear Corp. (OTCBB: UCLE)
    Robert I. Goldstein, President, CEO, and Chairman
    Ph: (818) 883 7043
    Email: info@usnuclearcorp.com
    http://www.usnuclearcorp.com

  • US Nuclear Corp. Partner Achieves Historic Milestone for Nuclear Fusion

    US Nuclear Corp. Partner Achieves Historic Milestone for Nuclear Fusion

    Good news for Cancer and Heart Patients

    Los Angeles, CA, Aug. 29, 2018 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — US Nuclear Corp. (UCLE):
    US Nuclear Corporation’s partner recently achieved a significant milestone in nuclear fusion by exceeding 1010 neutrons per pulse with MIFTEC Fusion power technology designed for use in US Nuclear Isotope generator. This historic, high-level neutron flux is far above what any other fusion company has ever achieved, and is a large step towards the final goal of producing medical isotopes in a localized medical setting.

    The method that US Nuclear Corp. and MIFTEC Laboratories Inc. are working to develop is simple, safe, and cost-effective. It uses an isotope of hydrogen as fuel, which is derived from seawater and is simple, safe, and cost-effective compared to the current method of using highly enriched or low enriched uranium (HEU/LEU) that results in dangerous, long-term radioactive byproducts.

    With US Nuclear being designated as the exclusive manufacturer of the MIFTEC isotope generators. And, with the radiopharmaceutical market currently a $10B USD worldwide industry, US Nuclear Corp. and MIFTEC Laboratories, Inc. plans to be a major market participant upon reaching final testing and implementation.

    (more…)